Results 1 to 10 of about 3,749 (163)
Some of the next articles are maybe not open access.
17-alpha hydroxyprogesterone caproate and risk for venous thromboembolism during pregnancy
The Journal of Maternal-Fetal & Neonatal Medicine, 202117-alpha hydroxyprogesterone caproate (17 P) is a progestin commonly used during pregnancy to reduce risk of recurrent preterm birth. History of thromboembolism is a contraindication to 17 P and the package insert for 17 P recommends discontinuation in the setting of an acute VTE event.
Meike, Schuster +7 more
openaire +2 more sources
The 17-alpha hydroxyprogesterone chronicle
American Journal of Obstetrics and Gynecology, 2022Jack Fitzsimmons, Wadia Mulla
openaire +2 more sources
The Use of 17 Alpha-Hydroxyprogesterone Caproate (17P) in Women with Cervical Cerclage
American Journal of Perinatology, 2008Our objective was to compare the incidence of recurrent spontaneous preterm delivery (SPTD) in patients with cervical cerclage treated with weekly 17 alpha-hydroxyprogesterone caproate (17P) injections versus daily outpatient nursing surveillance (ONS) without 17P.
Andrei, Rebarber +6 more
openaire +2 more sources
American Journal of Obstetrics and Gynecology, 2006
The purpose of this study was to identify the effect of early cessation of 17-alpha-hydroxyprogesterone caproate (17P) on the incidence of spontaneous recurrent preterm delivery (PTD).Retrospective analysis of data from women who were enrolled for outpatient 17P administration between January 2004 and May 2006 included women with previous PTD and ...
Andrei, Rebarber +6 more
openaire +2 more sources
The purpose of this study was to identify the effect of early cessation of 17-alpha-hydroxyprogesterone caproate (17P) on the incidence of spontaneous recurrent preterm delivery (PTD).Retrospective analysis of data from women who were enrolled for outpatient 17P administration between January 2004 and May 2006 included women with previous PTD and ...
Andrei, Rebarber +6 more
openaire +2 more sources
17 alpha-hydroxyprogesterone caproate, HIV, and preterm birth
The Lancet HIV, 2021Robert, Ntozini, Andrew J, Prendergast
openaire +2 more sources
Withdrawal of 17 alpha-hydroxyprogesterone: a possible trigger for preterm labor?
American Journal of Obstetrics and Gynecology, 2008TOTHEEDITORS:IreadwithinterestthearticlebyRebarber et al 1 concerning the early cessation of 17 alpha-hydroxyprogesterone caproate (17P) and its association with preterm delivery. In their observational study of a cohort of women receiving17Pforahistoryofapriorpretermdelivery,theauthors found that elective cessation of the medication prior to 32 weeks ...
openaire +1 more source
[Pharmacology of new gestagens: derivatives of 17-alpha-hydroxyprogesterone].
Farmakologiia i toksikologiia, 1989The experimental data on the pharmacological activity of the modified analogs++ of 17 alpha-hydroxyprogesterone are presented. A high gestagenic activity was shown to be related to the presence of the methyl group in position 6, the double bond in position C6-C7, the hydroxyl and acetoxy groups in position 3.
openaire +1 more source
[17 alpha-Hydroxyprogesterone].
Nihon rinsho. Japanese journal of clinical medicine, 2000Y, Shimizu, T, Yanaihara
openaire +1 more source
An ELISA for 17 alpha hydroxyprogesterone.
Steroids, 1989P A, Elder, K H, Yeo, J G, Lewis
openaire +1 more source